🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
From January 2020 to January 2025, Crohn's disease (CD) patients and gender...
Status
Completed
Location
the Second Affiliated Hospital of Wenzhou Medical University
Start Date
2020-01-01
Trial ID
NCT06935942
Treatments Being Tested
ustekinumab (UST) can effectively induce and maintain clinical remission an...
Status
Unknown
Location
SixthSunYetSen
Start Date
2023-06-01
Trial ID
NCT05861167
Treatments Being Tested
Ustekinumab (UST) is a novel biologic agent that targets and binds to Inter...
Status
Recruiting
Location
Sixth Affiliated Hospital, Sun Yat-sen University
Start Date
2024-08-01
Trial ID
NCT06912815
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of a treat to target ...
Status
Completed
Location
GZA Ziekenhuizen
Start Date
2017-04-19
Trial ID
NCT03107793
Treatments Being Tested
The goal of this observational study is to investigate the associations bet...
Status
Completed
Location
the Second Affiliated Hospital of Wenzhou Medical University
Start Date
2018-01-01
Trial ID
NCT07263464
Treatments Being Tested
This retrospective cohort study aims to compare the efficacy of different b...
Status
Recruiting
Location
The Tenth People's Hospital of Shanghai
Start Date
2026-01-16
Trial ID
NCT07694674
Treatments Being Tested
From January 2020 to January 2025, Crohn's disease (CD) patients and gender...
Status
Completed
Location
the Second Affiliated Hospital of Wenzhou Medical University
Start Date
2020-01-01
Trial ID
NCT06935929
Treatments Being Tested
This study intends to select patients with confirmed moderate-to-severe Cro...
Status
Recruiting
Location
Second Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2026-03-01
Trial ID
NCT07444060
Treatments Being Tested
The loss of response rate of ustekinumab(UST) is high, and the specific mec...
Status
Completed
Location
The Second Affiliated Hospital of Wenzhou Medical University
Start Date
2020-07-01
Trial ID
NCT06785493
Treatments Being Tested
The primary purpose of this study is to evaluate the efficacy and safety of...
Status
Unknown
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
Start Date
2023-02-15
Trial ID
NCT05705856
Treatments Being Tested